» Articles » PMID: 8143599

The Cytokinesis-block Micronucleus Technique and Its Application to Genotoxicity Studies in Human Populations

Overview
Date 1993 Oct 1
PMID 8143599
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The development of the cytokinesis-block (CB) technique has made the human lymphocyte micronucleus assay (MN) a reliable and precise method for assessing chromosome damage. Recent studies in our laboratory have confirmed that this method is a sensitive indicator of in vivo radiation exposure in patients undergoing fractionated partial-body radiotherapy and rodents exposed to uniform whole-body irradiation, thus supporting the application of the cytokinesis-block micronucleus (CBMN) assay for biological dosimetry. To further define the use of this assay in biomonitoring, we have also undertaken extensive studies to determine the spontaneous level of MN in normal human populations and its relationship to various lifestyle factors. During the past year, we have also developed a new variation to the CBMN assay that enables the conversion of excision-repairable lesions to MN within one cell-cycle using cytosine arabinoside. With this method the slope of the in vitro dose-response curves was increased by a factor of 1.8 for X-rays, 10.3 for ultraviolet (254 nm) radiation, and approximately 40-fold for methylnitrosourea. Consequently, the CBMN assay can now be used not only to measure whole chromosome loss or chromosome breaks but also excision repair events. The versatility and simplicity of the CBMN assay together with new developments in automation should enable its successful application in monitoring exposed populations as well as identifying mutagen-sensitive individuals within a population.

Citing Articles

Unraveling chromosomal and genotoxic damage in individuals occupationally exposed to coal from underground mining.

Buitrago-Rodriguez M, Rangel N, Vega-Valderrama J, Pulido-Medellin M, Rondon-Lagos M Front Genet. 2024; 15:1422938.

PMID: 39027885 PMC: 11254797. DOI: 10.3389/fgene.2024.1422938.


Genome- and Toxicology-Based Safety Assessment of Probiotic ONE Isolated from Humans.

Lv N, Wang C, Zhou H, Ma X, Yu X, Ren D Foods. 2024; 13(13).

PMID: 38998485 PMC: 11241434. DOI: 10.3390/foods13131979.


Characterization and Preliminary Safety Evaluation of PROBIO.

Ma X, Tian M, Yu X, Liu M, Li B, Ren D Foods. 2024; 13(3).

PMID: 38338577 PMC: 10855611. DOI: 10.3390/foods13030442.


Exploratory Study on Micronuclei and Metanuclear Abnormalities in Exfoliated Buccal Cells of COVID-19 Suspected Patients.

Vishnu B, Murugan S, Kalidoss V, Sesham K, Ramamurthy S, Bakshi S J Cytol. 2024; 41(1):28-33.

PMID: 38282807 PMC: 10810081. DOI: 10.4103/joc.joc_53_23.


Establishment of calibration curve for X-ray induced "dicentric + ring" and micronuclei in human peripheral lymphocytes for biodosimetry during radiological emergencies, and validation with dose blinded samples.

Vijayalakshmi J, Chaurasia R, Srinivas K, Vijayalakshmi K, Paul S, Bhat N Heliyon. 2023; 9(6):e17068.

PMID: 37484390 PMC: 10361230. DOI: 10.1016/j.heliyon.2023.e17068.


References
1.
BUCKTON K, Brown W, Smith P . Lymphocyte survival in men treated with x-rays for ankylosing spondylitis. Nature. 1967; 214(5087):470-3. DOI: 10.1038/214470a0. View

2.
Sorsa M, Anttila A, Jarventaus H, Kubiak R, Norppa H, Nylander L . Styrene revisited--exposure assessment and risk estimation in reinforced plastics industry. Prog Clin Biol Res. 1991; 372:187-95. View

3.
Preston R, GOOCH P . The induction of chromosome-type aberrations in G1 by methyl methanesulfonate and 4-nitroquinoline-N,-oxide, and the non-requirement of an S-phase for their production. Mutat Res. 1981; 83(3):395-402. DOI: 10.1016/0027-5107(81)90021-x. View

4.
Fenech M, Morley A . Measurement of micronuclei in lymphocytes. Mutat Res. 1985; 147(1-2):29-36. DOI: 10.1016/0165-1161(85)90015-9. View

5.
Peters L, Brock W, Johnson T, Meyn R, Tofilon P, Milas L . Potential methods for predicting tumor radiocurability. Int J Radiat Oncol Biol Phys. 1986; 12(4):459-67. DOI: 10.1016/0360-3016(86)90053-2. View